FDA product code QMZ: Digital Therapy Device To Reduce Sleep Disturbance For Psychiatric Conditions

QMZ is the FDA product code for digital therapy device to reduce sleep disturbance for psychiatric conditions. It is a Class II device, regulated under 21 CFR 882.5705 and reviewed by the Neurology panel. Devices under QMZ reach the market by 510(k); FDA lists no cleared 510(k)s for it. 1 De Novo request was granted under it.

Definition

A digital therapy device to reduce sleep disturbance for psychiatric conditions is a prescription device that is intended to provide stimulation using a general purpose computing platform to reduce sleep disturbance in patients who experience this symptom due to psychiatric conditions such as nightmare disorder or post traumatic stress disorder (PTSD).

Classification

FieldValue
Device nameDigital Therapy Device To Reduce Sleep Disturbance For Psychiatric Conditions
Device classClass II
Regulation21 CFR 882.5705
Review panelNE — Neurology
Medical specialtyNeurology
Premarket route510(k)

Recalls for QMZ devices

FDA recall records list no recalls for product code QMZ.

Frequently asked questions

What is FDA product code QMZ?

QMZ is the FDA product code for digital therapy device to reduce sleep disturbance for psychiatric conditions. It is a Class II device, regulated under 21 CFR 882.5705 and reviewed by the Neurology panel.

What device class is QMZ?

Class II, regulation 21 CFR 882.5705. Typical premarket route: 510(k).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Neurology product codes · FDA product code lookup · 510(k) database search · 510(k) review times